World Stroke Organization 
Maha Al-Istarabadi
Contributor biography
After completing her studies in medicine at the Medical University of Gdansk, Poland, she continued her education in Pharmacology and Biomedical Science at the University of Kalmar and MalmΓΆ University.
Currently, Maha Al-Istarabadi is a Neurology resident and member in the MS team at SkΓ₯ne University Hospital, MalmΓΆ, Sweden.
;
#MondayTip
From WSO/ICAA-A Cerebral Amyloid Angiopathy Statement
π―Management of antithrombotics in #CAA requires individualized, risk-balanced decision-making, given CAAβs intrinsically high risk of ICH
Phenotypic markers by @a_charidimou
Statement: https://doi.org/10.1177/17474930251365861
πWebinar on #StrokeSpasticity Management, Dec 11th, 3pm (CET)
π©βπ»Topics include global impact, optimizing #botulinumtoxin therapy & exploring #telerehabilitation to enhance recovery & patient outcomes
ποΈππππππππ: https://us02web.zoom.us/webinar/register/WN_gMpCwNTPSMWLKPkwSoKYFw#/registration
#StrokeEducation @Bayer
π΄We are #live! Join experts Ellis van Etten, @a_charidimou, David Werring and @SMGreenbergNeur to learn more about the diagnosis and management of #CerebralAmyloidAngiopathy (CAA).
πππππππ πππ: https://us02web.zoom.us/webinar/register/WN_z_OuKtEJQSui8CWbhP17cA#/
@WorldStrokeOrg @IntJStroke #StrokeEducation
What happened in #StrokeEducation in November? Time to read our newsletter!
ποΈhttps://www.world-stroke-academy.org/news/november-newsletter-2/
π’Webinars
π’PoM: Pre-Hospital Care w/ @IntJStroke
π’WSC2025 TV Studio w/ @OruenCNS
π’Meet The Trialist w/ @Bayer
π’#MondayTips by @interneurona
πππ©π©π² ππππ«π§π’π§π !
